Cargando…

Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia

Emerging studies suggest that dominant peripheral tolerance is a major mechanism of immune escape in disseminated leukemia. Using an established murine acute myeloid leukemia (AML) model, we here show that systemic administration of recombinant IL-33 dramatically inhibits the leukemia growth and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Lei, Dominguez, Donye, Chen, Siqi, Fan, Jie, Long, Alan, Zhang, Minghui, Fang, Deyu, Zhang, Yi, Kuzel, Timothy M., Zhang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308636/ https://www.ncbi.nlm.nih.gov/pubmed/27517629 http://dx.doi.org/10.18632/oncotarget.11179

Ejemplares similares

CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy
por: Chen, Siqi, et al.
Publicado: (2019)

WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
por: Zhang, Minghui, et al.
Publicado: (2018)

WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
por: Zhang, Minghui, et al.
Publicado: (2017)

IL-33–mediated Eosinophilia Protects against Acute Lung Injury
por: Krishack, Paulette A., et al.
Publicado: (2021)

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T-cell responses in a murine acute myeloid leukemia model
por: Stroopinsky, Dina, et al.
Publicado: (2021)

Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs
por: Patial, Sonika, et al.
Publicado: (2021)

Targeting CD33 for acute myeloid leukemia therapy
por: Liu, Jingjing, et al.
Publicado: (2022)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria
por: Shibui, Akiko, et al.
Publicado: (2015)

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
por: De Santis, Sara, et al.
Publicado: (2022)

Radiation-induced myeloid leukemia in murine models
por: Rivina, Leena, et al.
Publicado: (2014)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
por: Romão, Ema, et al.
Publicado: (2020)

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
por: Wang, Peihong, et al.
Publicado: (2021)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
por: Åbacka, Hannah, et al.
Publicado: (2021)

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
por: Sharma, Priyanka, et al.
Publicado: (2023)

CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
por: Albinger, Nawid, et al.
Publicado: (2022)

Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans Infections
por: Park, Sang Jun, et al.
Publicado: (2016)

Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds
por: Shen, Zhao-Hua, et al.
Publicado: (2016)

IL-33 promotes MHC class II expression in murine mast cells
por: Ito, Tomonobu, et al.
Publicado: (2015)

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg(®)) in children with relapsed/refractory myeloid leukemia
por: Brethon, Benoit, et al.
Publicado: (2006)

Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
por: Zhang, Yvyin, et al.
Publicado: (2023)

IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia
por: Jin, Rui, et al.
Publicado: (2020)

IL-37 Was Involved in Progress of Acute Myeloid Leukemia Through Regulating IL-6 Expression
por: Wei, Xiaonan, et al.
Publicado: (2021)

Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
por: Sun, Xiaoyan, et al.
Publicado: (2016)

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia
por: Zee, Barry M., et al.
Publicado: (2021)

An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
por: Przedborski, Michelle, et al.
Publicado: (2022)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
por: Song, Jiachun, et al.
Publicado: (2021)

IL-33 is produced by colon fibroblasts and differentially regulated in acute and chronic murine colitis
por: Waddell, Amanda, et al.
Publicado: (2021)

Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells
por: Chang, Jing, et al.
Publicado: (2017)

IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation
por: Zhang, Hai-Feng, et al.
Publicado: (2017)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
por: Laszlo, George S., et al.
Publicado: (2016)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
por: Joel Chandranesan, Andrew Stevenson, et al.
Publicado: (2018)

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
por: Kim, Dae Sik, et al.
Publicado: (2016)

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qfh5mkt21skj5g2ntlctbo3r4h